hydrazine has been researched along with Leukemia, Myelomonocytic, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ades, PL; Al Jijakli, A; Azerad, MA; Berceanu, A; Beyne-Rauzy, O; Broner, J; Cherait, A; Cluzeau, T; Comont, T; Cony-Makhoul, P; Dimicoli, S; Fenaux, P; Gaudin, C; Giraud, JT; Gruson, B; Guerveno, C; Guillaume, T; Gyan, E; Jachiet, V; Laribi, K; Le Clech, L; Meunier, M; Sanhes, L; Santana, C; Slama, B; Torregrosa, J | 1 |
| Gao, Y; Gong, M; Kong, X; Ma, Y; Zhang, C | 1 |
| Gauchan, D; Maroules, M; Modi, Y; Shaaban, H | 1 |
| Al Ali, N; Duong, VH; Komrokji, RS; Lancet, JE; List, AF; Padron, E; Ramadan, H; Zhang, L | 1 |
1 trial(s) available for hydrazine and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.
Topics: Aged; Aged, 80 and over; Benzoates; Female; Humans; Hydrazines; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Pyrazoles; Treatment Outcome | 2016 |
3 other study(ies) available for hydrazine and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.
Topics: Aged; Aged, 80 and over; Benzoates; Blood Platelets; Female; France; Humans; Hydrazines; Leukemia, Myelomonocytic, Chronic; Male; Myelodysplastic Syndromes; Pyrazoles; Receptors, Thrombopoietin; Retrospective Studies; Thrombocytopenia | 2021 |
Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Benzoates; Decitabine; Dioxygenases; DNA-Binding Proteins; Drug Monitoring; Female; Hematologic Agents; Humans; Hydrazines; Leukemia, Myelomonocytic, Chronic; Middle Aged; Mutation; Nuclear Proteins; Platelet Count; Proto-Oncogene Proteins; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Ribonucleoproteins; Serine-Arginine Splicing Factors; Thrombocytopenia; Thrombopoietin; Treatment Outcome | 2017 |
Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.
Topics: Benzoates; Humans; Hydrazines; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia; Treatment Outcome | 2015 |